Oncologists' Communication About Palliative Chemotherapy Survival Benefits
Author Information
Author(s): Audrey Suzanne, Abel Julian, Blazeby Jane M, Falk Stephen, Campbell Rona
Primary Institution: University of Bristol
Hypothesis
How much do oncologists communicate about the survival benefits of palliative chemotherapy during consultations?
Conclusion
Most patients were not given clear information about the survival gain of palliative chemotherapy.
Supporting Evidence
- 26 out of 37 consultations had vague or no discussion of survival benefit.
- Only 6 patients received numerical data about survival benefit.
- Patients often did not ask about survival benefit, leading to less information being shared.
Takeaway
Doctors often don't tell cancer patients how long palliative chemotherapy might help them live, which can make it hard for patients to make informed choices.
Methodology
Qualitative study observing and recording oncology consultations.
Potential Biases
Potential bias due to the presence of a researcher during consultations.
Limitations
The study had a small sample size and may not represent all oncology consultations.
Participant Demographics
37 patients with advanced cancer, including 13 men and 24 women, with various cancer types.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website